These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33298175)

  • 1. Men's willingness to pay for prostate cancer screening: a systematic review.
    Farabi H; Rezapour A; Moradi N; Aghamir SMK; Koohpayehzadeh J
    Syst Rev; 2020 Dec; 9(1):290. PubMed ID: 33298175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to Pay for Down Syndrome Screening: A systematics Review.
    Nikjoo S; Rezapour A; Moradi N; Nassiri S; Kabir A
    Med J Islam Repub Iran; 2022; 36():149. PubMed ID: 36700168
    [No Abstract]   [Full Text] [Related]  

  • 3. Difference in willingness-to-pay for prostate cancer screening between ill-informed and well-informed men: a contingent valuation survey.
    Yasunaga H; Sugihara T; Imamura T
    Urology; 2011 Jun; 77(6):1325-9. PubMed ID: 21507471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness-to-pay for a population-based-prostate-specific antigen screening for prostate cancer in Anambra State, Southeast, Nigeria: a contingent valuation study.
    Umeh BI; Ogbonna BO; Nduka SO; Nduka JI; Ejie LI; Mosanya UA; Ekwunife IO
    Afr Health Sci; 2022 Dec; 22(4):46-55. PubMed ID: 37092074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit evaluation of mass screening for prostate cancer: willingness-to-pay measurement using contingent valuation.
    Yasunaga H; Ide H; Imamura T; Ohe K
    Urology; 2006 Nov; 68(5):1046-50. PubMed ID: 17113896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to pay for mass screening for prostate cancer: a contingent valuation survey.
    Yasunaga H
    Int J Urol; 2008 Jan; 15(1):102-5; discussion 105. PubMed ID: 18184186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assigning value to preparation for prostate cancer decision making: a willingness to pay analysis.
    Wilson LS; Blonquist TM; Hong F; Halpenny B; Wolpin S; Chang P; Filson CP; Master VA; Sanda MG; Chien GW; Jones RA; Krupski TL; Berry DL
    BMC Med Inform Decis Mak; 2019 Jan; 19(1):6. PubMed ID: 30626400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor associated with willingness to pay for prevention of cancer: a study of prostate cancer screening.
    Farabi H; Moradi N; Ahmadzadeh A; Agamir SMK; Mohammadi A; Rezapour A
    Cost Eff Resour Alloc; 2023 Nov; 21(1):89. PubMed ID: 37990328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to Pay for Colorectal Cancer Screening in Vietnam: Policy Implications From a Contingent Valuation Survey.
    Nguyen HT; Nguyen AQ
    Value Health Reg Issues; 2023 Nov; 38():29-37. PubMed ID: 37441860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review.
    Vernooij RWM; Lytvyn L; Pardo-Hernandez H; Albarqouni L; Canelo-Aybar C; Campbell K; Agoritsas T
    BMJ Open; 2018 Sep; 8(9):e025470. PubMed ID: 30185585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to pay for a National Health Insurance Scheme in The Gambia: a contingent valuation study.
    Njie H; Wangen KR; Chola L; Gopinathan U; Mdala I; Sundby JS; Ilboudo PGC
    Health Policy Plan; 2023 Jan; 38(1):61-73. PubMed ID: 36300926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to pay for packaging cancer screening of Chinese rural residents.
    Zhang Q; Ren D; Chang X; Sun C; Liu R; Wang J; Zhang N
    Cancer Med; 2023 Feb; 12(3):3532-3542. PubMed ID: 36000818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel.
    Ben-Aharon O; Sergienko R; Iskrov G; Greenberg D
    Isr J Health Policy Res; 2024 Feb; 13(1):9. PubMed ID: 38374060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Longitudinal Investigation of Willingness to Pay for Health Insurance in Germany.
    Bock JO; Hajek A; Brenner H; Saum KU; Matschinger H; Haefeli WE; Schöttker B; Quinzler R; Heider D; König HH
    Health Serv Res; 2017 Jun; 52(3):1099-1117. PubMed ID: 27324300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to pay for cancer prevention, screening, diagnosis, and treatment: a systematic review.
    Ben-Aharon O; Iskrov G; Sagy I; Greenberg D
    Expert Rev Pharmacoecon Outcomes Res; 2023 Mar; 23(3):281-295. PubMed ID: 36635646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of willingness to pay for health services: a systematic review of contingent valuation studies.
    Steigenberger C; Flatscher-Thoeni M; Siebert U; Leiter AM
    Eur J Health Econ; 2022 Dec; 23(9):1455-1482. PubMed ID: 35166973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to pay for health insurance among the elderly population in Germany.
    Bock JO; Heider D; Matschinger H; Brenner H; Saum KU; Haefeli WE; König HH
    Eur J Health Econ; 2016 Mar; 17(2):149-58. PubMed ID: 25526928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-financing for viral load monitoring during the course of antiretroviral therapy among patients with HIV/AIDS in Vietnam: A contingent valuation survey.
    Nguyen QL; Nguyen LH; Tran BX; Phan HT; Le HT; Nguyen HD; Tran TD; Do CD; Nguyen CM; Thuc VT; Latkin C; Zhang MW; Ho RC
    PLoS One; 2017; 12(2):e0172050. PubMed ID: 28199405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness-to-pay for cancer treatment and outcome: a systematic review.
    Yong ASJ; Lim YH; Cheong MWL; Hamzah E; Teoh SL
    Eur J Health Econ; 2022 Aug; 23(6):1037-1057. PubMed ID: 34853930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.